Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma
Elaine Y. Chung, Yun Mai, Urvi A. Shah, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 12, pp. 3589-3601
Open Access | Times Cited: 21

Showing 21 citing articles:

PAK and PI3K pathway activation confers resistance to KRASG12C inhibitor sotorasib
Chien-Hui Chan, Li-Wen Chiou, Tsai‐Yu Lee, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 1, pp. 148-159
Open Access | Times Cited: 31
The role of cell division control protein 42 in tumor and non-tumor diseases: A systematic review
Junjie Fu, Bo Liu, Hao Zhang, et al.
Journal of Cancer (2022) Vol. 13, Iss. 3, pp. 800-814
Open Access | Times Cited: 25
Phosphoproteomics identifies determinants of PAK inhibitor sensitivity in leukaemia cells
Pedro Casado, Santiago Marfà, Marym M. Hadi, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Recent advances on development of p21-activated kinase 4 inhibitors as anti-tumor agents
Yang Li, Qing Lu, Cheng-Hu Xie, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
p21-Activated kinases as promising therapeutic targets in hematological malignancies
Andrew Wu, Xiaoyan Jiang
Leukemia (2021) Vol. 36, Iss. 2, pp. 315-326
Closed Access | Times Cited: 20
Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
Weina Kong, Gang Zhao, Haixia Chen, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Systemic analysis of the expression and prognostic significance of PAKs in breast cancer
Yifang Dang, Ying Guo, Xiaoyu Ma, et al.
Genomics (2020) Vol. 112, Iss. 3, pp. 2433-2444
Open Access | Times Cited: 15
NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
Markéta Šašinková, Petr Heřman, Aleš Holoubek, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Targeting P21-activated kinase suppresses proliferation and enhances chemosensitivity in T-cell lymphoblastic lymphoma
Ning Su, Fang Yu, Xu Chen, et al.
Blood Science (2023) Vol. 5, Iss. 4, pp. 249-257
Open Access | Times Cited: 3
Regulation of human T-cell leukemia virus type 1 antisense promoter by myocyte enhancer factor-2C in the context of adult T-cell leukemia and lymphoma
Kiran Madugula, Julie Joseph, Catherine DeMarino, et al.
Haematologica (2022) Vol. 107, Iss. 12, pp. 2928-2943
Open Access | Times Cited: 5
ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent
Rebecca A. Luchtel, Yongmei Zhao, Ritesh K. Aggarwal, et al.
Blood Advances (2022) Vol. 6, Iss. 20, pp. 5613-5624
Open Access | Times Cited: 5
High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma – implications for staging
Ana Acuña-Villaorduña, Jesus D. Gonzalez‐Lugo, B. Hilda Ye, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2019) Vol. 60, Iss. 13, pp. 3272-3276
Open Access | Times Cited: 6
The Combined Use of Orf Virus and PAK4 Inhibitor Exerts Anti-tumor Effect in Breast Cancer
Hao Deng, Bin Xiao, Yinger Huang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 4
Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant Eµ-Myc lymphoma cells
Jill V. Hunter, A. Campbell, Scott Kerridge, et al.
Biochemical Journal (2022) Vol. 479, Iss. 19, pp. 2131-2151
Open Access | Times Cited: 4
The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma
Makoto Nakashima, Atae Utsunomiya, Toshiki Watanabe, et al.
Cancer Science (2022) Vol. 114, Iss. 4, pp. 1556-1568
Open Access | Times Cited: 4
The potential for new and resilient anti-cancer drugs based upon minor groove binders for DNA
Fraser J. Scott, Colin J. Suckling
Medical Research Archives (2021) Vol. 9, Iss. 11
Open Access | Times Cited: 4
Acetyl transferase EP300 deficiency leads to chronic replication stress mediated by defective fork protection at stalled replication forks
Angelica Barreto-Galvez, Mrunmai Niljikar, Julia Gagliardi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
Markéta Šašinková, Petr Heřman, Aleš Holoubek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
Melanoma-associated brain metastasis: Molecular mechanisms and therapeutic options
Ioana Todoran
(2022)
Open Access
Over-representation of MEF-2 isoforms (A/C) is associated with HTLV-1-induced acute ATLL and their recruitment to 3’LTR facilitates HBZ expression from the antisense promoter via interactions with Menin and Jun D
Kiran Madugula, Julie Joseph, Vanessa Teixeira, et al.
Research Square (Research Square) (2021)
Open Access
Analysis of Therapeutic Targets and Prognostic Biomarkers of CXC Chemokines in Cervical Cancer Microenvironment
Wei Kong, Gang Zhao, Hai xia Chen, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top